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Abstract
Background: Although breast-feeding accounts for 15–20% of mother-to-child transmission (MTCT) of
HIV, it is not prohibited in some developing countries because of the higher mortality associated with not
breast-feeding. We assessed the potential impact, on HIV infection and infant mortality, of a
recommendation for shorter durations of exclusive breast-feeding (EBF) and poor compliance to these
recommendations.
Methods: We developed a deterministic mathematical model using primarily parameters from published
studies conducted in Uganda or Kenya and took into account non-compliance resulting in mixed-feeding
practices. Outcomes included the number of children HIV-infected and/or dead (cumulative mortality) at
2 years following each of 6 scenarios of infant-feeding recommendations in children born to HIV-infected
women: Exclusive replacement-feeding (ERF) with 100% compliance, EBF for 6 months with 100%
compliance, EBF for 4 months with 100% compliance, ERF with 70% compliance, EBF for 6 months with
85% compliance, EBF for 4 months with 85% compliance
Results: In the base model, reducing the duration of EBF from 6 to 4 months reduced HIV infection by
11.8% while increasing mortality by 0.4%. Mixed-feeding in 15% of the infants increased HIV infection and
mortality respectively by 2.1% and 0.5% when EBF for 6 months was recommended; and by 1.7% and 0.3%
when EBF for 4 months was recommended. In sensitivity analysis, recommending EBF resulted in the least
cumulative mortality when the a) mortality in replacement-fed infants was greater than 50 per 1000
person-years, b) rate of infection in exclusively breast-fed infants was less than 2 per 1000 breast-fed
infants per week, c) rate of progression from HIV to AIDS was less than 15 per 1000 infected infants per
week, or d) mortality due to HIV/AIDS was less than 200 per 1000 infants with HIV/AIDS per year.
Conclusion: Recommending shorter durations of breast-feeding in infants born to HIV-infected women
in these settings may substantially reduce infant HIV infection but not mortality. When EBF for shorter
durations is recommended, lower mortality could be achieved by a simultaneous reduction in the rate of
progression from HIV to AIDS and or HIV/AIDS mortality, achievable by the use of HAART in infants.
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An estimated 2.3 million children under 15 years were liv-
ing with human immunodeficiency virus (HIV) infection,
and 700,000 children were newly infected in 2005 alone
[1]. Ninety percent of these HIV infections were acquired
through mother-to-child-transmission (MTCT). Vertical
transmission of the HIV virus from mother to child can
occur during pregnancy, delivery or postnatal through
breast-milk [2]. Rates of MTCT range from 5–25% in
developed and 13–42% in developing countries[3]. Data
from various studies indicate that breast-feeding may be
responsible for one-third to one-half of HIV infections in
infants and young children in Africa[2].
The reduction of HIV transmission during lactation is one
of the most pressing global health dilemmas confronting
health policy makers and HIV-infected women in many
regions of the world [4-6]. Replacement-feeding prevents
breast-milk transmission of HIV. However, in resource-
limited settings, access to replacement-feeding is hindered
by costs, poor water quality and sanitation, cultural prac-
tices and stigma associated with not breast-feeding [7-9].
In addition, the protection offered by breast-feeding
against diarrheal and respiratory diseases which cause
high infant mortality rates, needs to be weighed against
the risk of transmitting HIV.
It has long been recommended that women who are HIV
positive should avoid breast-feeding and use replacement-
feeding when it is acceptable, feasible, affordable, sustain-
able and safe (AFASS) [10]. In cases were this is not possi-
ble, exclusive breast-feeding is recommended for the first
months of life, followed by rapid weaning as soon as it is
feasible, depending on the individual woman's situation,
and taking into account the possible increased risk of HIV
transmission with mixed-feeding during the transition
period between exclusive breast-feeding and complete
cessation of breast-feeding.
Several researchers have modeled the risks and benefits of
replacement versus breast-feeding for HIV-infected moth-
ers in developing countries [6,7,11-18]. However, these
modeling studies primarily examined the impact of exclu-
sive breast-feeding versus replacement-feeding with little
attention to the recommended duration of exclusive
breast-feeding or the impact of poor compliance to these
recommendations.
Taking these limitations into consideration, we developed
a model that examined the potential impact of different
infant-feeding recommendations on the overall mortality,
burden of HIV and AIDS in children less than 2 years of
age, and also examined the impact of varying the duration
of breast-feeding and the rate of compliance to infant-
feeding recommendations. We chose a priori to derive
parameter sources for this model from Uganda and
Kenya, two East African countries where the epidemiology
is relatively well documented. In addition, we assessed the
impact of variations to the chosen parameters through a
sensitivity analysis. In contrast to previous models of
time-to-death as a single outcome, we chose to model
both cumulative mortality and infection proportions at 2
years. Our choice of these two outcome measures was
designed to address the fact that communities may be as
concerned with the number of children living with HIV/
AIDS after a certain time period as they could be about the
number of children dead. Further, cumulative propor-
tions of children living with HIV/AIDS or dead represent
statistics that are easy-to-interpret and understand and
thus are at least as useful as time-to-event statistics (haz-
ard or rates).
Methods
Model characteristics
We developed a compartmental, deterministic model to
simulate the effects of different breast-feeding recommen-
dations in HIV-infected women in a typical sub-Saharan
setting (Figure 1). This type of model was chosen for its
simplicity and the direct interpretation of results. This
model simulated a population of N children born to
women who were HIV-positive during pregnancy. A pro-
portion (p) of these children were infected at birth, whilst
(1-p), of the N children were born HIV-negative. Though,
in practice, infants' HIV status is usually based on a PCR
test at 6 weeks, we assumed that infants who tested posi-
tive at 6 weeks were positive right from birth. Infants born
infected with HIV (I), can later progress to develop AIDS
(A). Non-infected infants were distributed according to
their feeding mode into the following three compart-
ments; exclusively breast-fed (B), mixed-fed (M), and
replacement-fed (F), representing the proportions b, m, f
respectively. In our model, exclusive breast-feeding was
defined as feeding the infant breast-milk only, mixed-
feeding was defined as feeding the infant breast-milk and
other non-breast-milk liquids, and replacement-feeding
meant that the infant was not given breast-milk but other
non-breast-milk liquids. Non-infected infants could even-
tually get HIV-infected (I), and HIV-infected infants could
progress to AIDS (A). Death could result from AIDS and
AIDS-related causes or from non-AIDS related causes.
The model assumed that post-natal HIV transmission
occurred solely through breast-feeding with no difference
in the HIV transmission rates by gender. Exclusively
breast-fed infants were infected with HIV at a rate of λB
while infants receiving mixed-feeding were infected at a
rate of λM. Evidence for higher HIV transmission in infants
receiving mixed-feeding when compared to exclusively
breast-fed infants[19] was taken into account by using val-
ues of λM that were higher than λB. We assumed that pre-Page 2 of 13
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the mother did not have any effect on the cumulative 2-
year postpartum risk of HIV transmission through breast-
feeding. The base model assumed no use of ART in the
postpartum period (as this is not a common practice in
many developing countries)[10]. This assumption how-
ever was relaxed in the sensitivity analysis by varying λM
and λB.
In addition, we assumed that the risk of HIV transmission
in breast milk is constant[20]. By using an average value
for transmission risk, we underestimate the rate in periods
of truly high transmission, but this is compensated by
overestimating the estimates in periods of truly low trans-
mission such that outcome measures of cumulative pro-
portions remain valid estimates. HIV-infected infants
progressed to AIDS at a rate γ, estimated from the inverse
of the average duration from HIV infection to the onset of
AIDS in infants. The model assumed that progression
from HIV to AIDS did not depend on the mode of feeding.
Infants with AIDS died at a rate of µA. We assumed that the
mortality in HIV-infected children was mainly due to
AIDS-related illness (with non-AIDS related mortality
being negligible).
Weaning in exclusively breast-fed infants and infants
receiving mixed-feeding occurred at a rate δ; for this sim-
ulation, weaning was assumed to be abrupt. This rate was
estimated from the inverse of the average duration of
breast-feeding in the population. Mortality rates in unin-
fected infants depended on the mode of feeding with
infants receiving exclusively breast-milk, no breast-milk
and mixed-feeding dying at rates of µB, µF, and µM, respec-
tively.
The following differential equations, with a time step of
one week, were used to model the weekly rate at which
infants moved in and out of compartments. B(t), F(t),
M(t), I(t), and A(t), represented the number of infants
respectively in compartments B, F, M, I and A at time t.
dB/dt = b(1-p)N - [λB + δ + µB]B(t) (1)
dF/dt = f(1-p)N + δ[B(t) + M(t)] - µFF(t) (2)
dM/dt = m(1-p)N - [λM + δ + µM]M(t) (3)
dI/dt = pN + λBB(t) + λMM(t) - γI(t) (4)
dA/dt = γI(t) - µAA(t) (5)
dD/dt = µAA(t) + µBB(t) + µFF(t) + µMM(t) (6)
Six unique infant-feeding scenarios were analyzed (Table
1): these were defined by the recommended mode and
duration of feeding as well as compliance to the breast-
feeding recommendation in the population of HIV-
infected women. Breast-feeding could be prohibited in all
infants (scenarios U and X), or breast-feeding could be
recommended for a duration of 6 months (scenarios V
and Y) or for a duration of 4 months (scenarios W and Z).
Three of these scenarios are idealistic, (U, V, W) assuming
complete (100%) compliance while the other three sce-
narios (X, Y, Z) were more realistic assuming 85% compli-
ance in exclusively breast-fed infants and 70% compliance
in infants not breast-fed [21-23].
The primary model outcomes were: the cumulative mor-
tality at 2 years (104 weeks) defined as Dt = 104/N, the pro-
Model compartment and parametersFigure 1
Model compartment and parameters.
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(It = 104 + At = 104)/N, and the proportion of children either
living with HIV/AIDS or dead at 2 years defined as Dt = 104
+ It = 104 + At = 104/N. It is worth noting that the latter com-
bined measure counts each infant only once (not twice).
Because this is a compartmental model, at any given time
each infant is in one and only one compartment. So at
time 2-year, infants who died from HIV will be in the D
compartment, not in the I compartment. The assessment
endpoint was set a priori at 2 years with the assumption
that infant-feeding patterns negligibly affected child mor-
tality after 2 years.
Parameter estimates
Estimates of parameters used in the model were obtained
from published articles from a Medline search using the
MeSH keywords "Infant + Feeding + HIV" as well as guide-
line documents published by the World Health Organiza-
tion publication (WHO). Because of the heterogeneity in
parameter values across regions, the parameters were cho-
sen primarily from studies conducted in Kenya or
Uganda. For estimates that were not documented in these
two countries we used projections from other countries in
the region (with similar epidemiology). The specific val-
ues used for each parameter are shown in Table 2.
Sensitivity analysis
Sensitivity analyses were conducted to evaluate the poten-
tial impact of the choice of parameters. We performed
univariate sensitivity analyses, varying one parameter
while holding the rest of the parameters in the model con-
stant. The following parameters were varied: the recom-
mended duration of breast-feeding from 1 to 6 months;
compliance to the recommended infant-feeding from 10
to 100%, the proportion of infants born HIV-infected
from 1% to 25%; the mortality rates in breast-fed, mixed-
fed and replacement-fed infants from 0 to 200 per thou-
sand children, taking into account differences in access to
clean water and health care facilities according to geo-
graphical settings. Parameters that could be influenced by
the greater availability of anti-retroviral therapy such as
the rate of infection in breast-fed infants, the rate of pro-
gression from HIV to AIDS and the mortality rate due to
HIV/AIDS were also varied.
Results
Base model
In the scenarios with 100% compliance (scenarios U, V,
W) to the infant-feeding recommendations, exclusive
replacement-feeding (scenario U) resulted in the least
number of children with HIV/AIDS at 2 years (Figure 2).
The proportion of children with HIV/AIDS at 2 years was
6.2%, 8.6% and 9.7% for replacement-fed, and infants
breast-fed for 4 or 6 months respectively. However, the
cumulative mortality at 2 years was very similar for each
of the three scenarios: 10.55% in infants who had replace-
ment-feeding compared to 10.57% in infants who were
breast-fed for 4 months and 10.53% for infants breast-fed
for 6 months. Considering all the outcomes, HIV/AIDS
and mortality at 2 years together, replacement-feeding
was the best feeding option if there was 100% compliance
(scenario U, Figure 2) as it resulted in the least number of
children affected by HIV/AIDS or death, while breast-feed-
ing for 6 months (scenario V) had the highest combined
morbidity/mortality.
Taking into account the limited compliance to recom-
mendations and assuming 70% compliance when
Table 1: Characteristics of scenarios considered in modeling the potential impact of different breast-feeding recommendations in 
children born to HIV-infected women in sub-Saharan Africa
Idealistic scenarios Realistic* scenarios
Recommendation All infants not 
breast-fed (U)
All infants 
exclusively 
breast-fed for 6 
months (V)
All infants 
exclusively 
breast-fed for 4 
months (W)
All infants not 
breast-fed (X)
All infants 
exclusively 
breast-fed for 6 
months (Y)
All infants 
exclusively 
breast-fed for 4 
months (Z)
Proportion Not 
breast-fed (f)
1.00 0.00 0.00 0.70 0.00 0.00
Proportion 
exclusively breast-
fed (b)
0.00 1.00 1.00 0.00 0.85 0.85
Proportion on 
mixed-feeding (m)
0.00 0.00 0.00 0.30 0.15 0.15
Recommended 
breast-feeding 
duration (1/δ 
months)
NA 6 4 NA 6 4
* Realistic scenarios assume 85% compliance in exclusively breast-fed infants and 70% compliance in replacement-fed infants [21–23].Page 4 of 13
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85% compliance when exclusive breast-feeding (for 4
(scenario Z) or 6 months (scenario Y)) was recom-
mended, the number of infants infected with HIV, and
having AIDS at 2 years was still lower with replacement-
feeding compared to exclusive breast-feeding for 4 or 6
months. However, compared to the scenario where there
was 100% compliance, the number of children with HIV/
AIDS at 2 years increased by 24% for replacement-feeding
with 70% compliance (scenario U vs. X). By contrast, the
number of children with HIV/AIDS at 2 years increased
only by 1.7% (scenario W vs. Z) and 2.1% (scenario V vs.
Table 2: Definition, values and sources of parameters used in modeling the potential impact of different breast-feeding 
recommendations in children born to HIV-infected women in sub-Saharan Africa
Parameter Definition Base model Source of estimates
N Population size of children born to HIV-infected women 100000 -
P Proportion of infants born HIV positive 0.08 [25]
λB Rate of HIV infection from exclusive breast-feeding (cases/person-week) 0.0019 [21, 23]λM Rate of HIV infection from mixed-feeding (cases/person-week) 0.0027 [26]*Γ Rate of progression from HIV to AIDS= (average duration of non-AIDS HIV infection)-1 0.016 [27]
µM Mortality rate in mixed-fed infants (per person-week) 0.00087 **µF Mortality rate in replacement-fed infants (per person-week) 0.00096 [28]µB Mortality rate in exclusively breast-fed infants (per person-week) 0.00078 [28]µA Mortality rate due to HIV/AIDS (per person-week) 0.005 [28]
B Proportion of uninfected infants at birth that are exclusively breast-fed † -
F Proportion of uninfected infants at birth that are exclusively replacement-fed † -
M Proportion of uninfected infants at birth that receive mixed feeding † -
* In the absence of specific estimates in Uganda/Kenya, used this study to estimate that transmission rate in mixed fed is 40% higher than that in 
exclusively breast-fed.
** In the absence of data: mortality in mixed-fed infants was assumed to be the mean of the mortality in exclusively breast-fed and replacement-fed 
infants.
† Values varied by scenario (see Table 1)
Base model of six infant-feeding scenarios in 100,000 infants born to HIV+ mothers: Number of Children with HIV/AIDS, dead, or both at 2 yearsFigure 2
Base model of six infant-feeding scenarios in 100,000 infants born to HIV+ mothers: Number of Children with 
HIV/AIDS, dead, or both at 2 years. U: Exclusive replacement-feeding (ERF) with 100% compliance; V: EBF for 6 months 
with 100% compliance; W: EBF for 4 months with 100% compliance: X: ERF with 70% compliance; Y: EBF for 6 months with 
85% compliance; Z: EBF for 4 months with 85% compliance.
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months respectively, when compliance was 85% versus
100%. The cumulative mortality increased only by 0.9%,
0.3% and 0.5% in children who had replacement-feeding
(scenario U vs. X) or were breast-fed for 4 (scenario W vs.
Z) and 6 months (scenario V vs. Y) respectively when
compliance was reduced from 100% to 70% for replace-
ment-feeding and 85% for exclusive breast-feeding. When
limited compliance was taken into account, the least total
number of children with HIV/AIDS or dead at 2 years was
obtained when replacement-feeding was recommended
(scenario X), followed by exclusive breast-feeding for 4
months (scenario Z) and lastly, exclusive breast-feeding
for 6 months(scenario Y) (Figure 2).
Sensitivity analysis
Duration of breast-feeding
With 100% compliance, increasing the recommended
duration of breast-feeding resulted in an increase in the
number of children infected with HIV/AIDS (Figure 3a).
When compliance was 70% for the replacement-feeding
recommendation (scenario X), the number of children
with HIV/AIDS also increased with any increase in the rec-
ommended duration of breast-feeding.
Varying the recommended duration of breast-feeding had
very little impact on the cumulative mortality – between
10.5% and 10.7% of all infants were dead at 2 years irre-
spective of scenario or duration (Figure 3b). Despite this
limited overall impact, increasing the recommended
duration of breast-feeding from 1 to 2 months resulted in
an initial increase in 2-year cumulative mortality. The
maximum mortality was attained at a recommended
duration between 2 and 3 months, followed by a progres-
sive decline in cumulative mortality as the duration
increased to 6 months. Compared to replacement-feed-
ing, slightly fewer infants were dead at 2 years only when
exclusive breast-feeding for more than 5 months was rec-
ommended.
With a reduced compliance of 70%, cumulative mortality
increased in infants who had replacement-feeding (sce-
nario X) with increased recommended duration of breast-
feeding (Figure 3b). By contrast, a reduced compliance of
85% following a recommendation of exclusive breast-
feeding (scenario Y, Z) resulted in an initial increase in
cumulative mortality, with a maximum being attained
when breast-feeding was recommended for 3–4 months
(Figure 3b). Furthermore, recommending breast-feeding
for 3 months or more (with reduced compliance) (sce-
nario Y, Z) resulted in fewer deaths than recommending
replacement-feeding with reduced compliance (scenario
X).
Compliance to recommended infant-feeding method
For all scenarios, decreasing the compliance to recom-
mended infant-feeding methods resulted in an increase in
the number of children infected with HIV and or dead at
2 years (Figure 4c). The impact of compliance on HIV
infection and/or cumulative mortality was highest with
replacement-feeding than it was with breast-feeding.
Though, with 100% compliance, recommending breast-
feeding for 4 months (scenario W) resulted in slightly
more deaths than recommending breast-feeding for 6
months (scenario V) or replacement-feeding (scenario U),
mortality in all 3 scenarios was very similar with a compli-
ance of 60% or less.
Absolute and relative mortality rate in infants not breast-fed
Varying the mortality rate in replacement-fed infants did
not impact the total number of children with HIV/AIDS at
2 years (Additional file 1a and Figure 5a). Nevertheless
increasing the absolute value of the mortality rate in
replacement-fed infants (Additional file 1b) or the relative
mortality in replacement-fed compared to breast-fed
infants (Figure 5b) resulted in an increase in the cumula-
tive mortality, irrespective of feeding recommendation.
The increase was highest in replacement-fed infants.
Although with a mortality rate less than 50 per 1000 per
year, the cumulative mortality was lowest when replace-
ment-feeding was recommended, the cumulative mortal-
ity in this scenario became highest when the mortality rate
surpassed 50 per 1000 per year. Considering the total
number of children with HIV/AIDS or dead at 2 years as
the outcome (Additional file 1c), an equilibrium between
all six scenarios was reached at a higher mortality rate:
though recommending replacement feeding resulted in
the lowest number of children with HIV/AIDS or dead
when the mortality rate in replacement-fed was less than
150 per 1000 per year, it resulted in the highest number of
children with HIV/AIDS when the mortality rate in
replacement-fed was higher than 150 per 1000 per year. In
terms of relative mortality, the equilibrium was reached
when the mortality rate in replacement-fed infants was 3–
4 fold that in breast-fed infants: recommending replace-
ment-feeding results in the least number of children with
HIV/AIDS or dead when the mortality rate in replace-
ment-fed infants is less than 3 fold that in breast-fed
infants, while the same recommendation results in the
most number of children with HIV/AIDS or dead when
the mortality rate in replacement-fed is more than 4 times
that in breast-fed infants.
Rate of infection in breast-fed infants
Increasing the infection rate in breast-fed infants resulted
in a higher number of children with HIV/AIDS and a
higher cumulative death at 2 years in all breast-feeding
scenarios (Additional file 2c). These numbers (of infected
or dead children at 2 years) were even higher with a longerPage 6 of 13
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(a-c): Impact of Duration of Breast-feeding on the Number of Children with HIV/AIDS (top graph), dead (middle graph) or both (bottom graph) at 2 yearsFigure 3
(a-c): Impact of Duration of Breast-feeding on the Number of Children with HIV/AIDS (top graph), dead (mid-
dle graph) or both (bottom graph) at 2 years. U: Exclusive replacement-feeding (ERF) with 100% compliance; V: EBF for 
6 months with 100% compliance; W: EBF for 4 months with 100% compliance: X: ERF with 70% compliance; Y: EBF for 6 
months with 85% compliance; Z: EBF for 4 months with 85% compliance.
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(a-c): Impact of Compliance to Feeding Recommendations on the Number of Children with HIV/AIDS (top graph), dead (mid-dle graph) or both (bottom graph) at 2 y arsFigu e 4
(a-c): Impact of Compliance to Feeding Recommendations on the Number of Children with HIV/AIDS (top 
graph), dead (middle graph) or both (bottom graph) at 2 years. U: Exclusive replacement-feeding (ERF) with 100% 
compliance; V: EBF for 6 months with 100% compliance; W: EBF for 4 months with 100% compliance: X: ERF with 70% compli-
ance; Y: EBF for 6 months with 85% compliance; Z: EBF for 4 months with 85% compliance.
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(a-c): Impact of the relative mortality rate in replacement compared to breast-fed infants on the Number of Children with HIV/AIDS (top), dead (middle) or both (bot om graph) at 2 yearsFigure 5
(a-c): Impact of the relative mortality rate in replacement compared to breast-fed infants on the Number of 
Children with HIV/AIDS (top), dead (middle) or both (bottom graph) at 2 years. U: Exclusive replacement-feeding 
(ERF) with 100% compliance; V: EBF for 6 months with 100% compliance; W: EBF for 4 months with 100% compliance: X: ERF 
with 70% compliance; Y: EBF for 6 months with 85% compliance; Z: EBF for 4 months with 85% compliance.
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breast-fed infants was however similar to that of replace-
ment-fed infants when the rate of infection was in the
order of 2 per 1000 per week.
Rate of progression from HIV to AIDS in infants
Though varying the HIV to AIDS progression rate did not
impact the total number of children with HIV/AIDS or
dead at 2 years, increasing the rate resulted in an exponen-
tial decrease (with little change beyond a rate of 30 per
1000 per week) in the number of children with HIV/AIDS
at 2 years (Additional file 3a). Concurrently, increasing
the rate resulted in an increase in the number of children
dead at 2 years (Additional file 3b). The rate of increase
was however lowest when replacement-feeding was rec-
ommended. Thus, although the mortality in replacement-
fed infants was highest with low progression rates, recom-
mending replacement-feeding with a high compliance
resulted in the least deaths when the progression rate was
higher than 20 per 1000 per week.
Mortality rate due to HIV/AIDS in infants
Varying the HIV/AIDS mortality rate did not affect the
total number of children with HIV/AIDS or dead at 2 years
(Additional file 4c). Nevertheless, increasing the rate
resulted in a decrease in the number of children with HIV/
AIDS at 2 years (Additional file 4a), and an increase in the
number of children dead at 2 years (Additional file 4b).
Despite resulting in the highest number of deaths at 2
years when HIV/AIDS mortality was low, replacement-fed
infants had the least number of deaths at 2 years when
HIV/AIDS mortality rate was higher than 300 per 1000
per year (Additional file 4b).
Discussion
Policy makers and care-providers in resource-limited,
high HIV-prevalence settings continue to be confronted
with the dilemma of what feeding method and duration
to recommend for infants born to HIV-infected children.
In order to reflect conditions specific to these settings, we
used epidemiologic parameters only from studies con-
ducted in sub-Saharan studies to analyze the potential
impact of 3 infant-feeding recommendations on the mor-
bidity and/or mortality in these infants. Our analysis sug-
gests that the choice of preferred infant-feeding method
depends on the policy makers' objective: to minimize the
number of children with HIV/AIDS, to minimize the
cumulative mortality, or to minimize the total number of
children with HIV/AIDS or dead. Most previous discus-
sions of this issue have focused on infant mortality. This
view assumes that communities will prefer minimizing
deaths irrespective of the number of children that end up
living with HIV. However, there is no evidence supporting
this. It is our view that not only should the mortality be
considered but also the number of children affected by
HIV/AIDS either separately or combined with the total
number of deaths. Thus an important prerequisite in the
choice of feeding method should be a definition of each
society's preferences and or perceptions towards mortality
versus living with HIV/AIDS.
As expected, recommending breast-feeding increased the
number of children infected with HIV while recommend-
ing replacement-feeding increased infant mortality. How-
ever there was only a minimal decrease in cumulative
mortality when breast-feeding was recommended. Breast-
feeding seemed to simply delay the timing of death rather
than reduce it altogether: while breast-feeding reduced
mortality at the very young ages, infants got infected and,
consistent with the conditions existing in most resource
limited settings, these infants progressed to AIDS rela-
tively rapidly, and died later on by the age of two. Breast-
feeding for a shorter duration (4 months as has been sug-
gested) actually increased mortality, an increase that was
accentuated when there was poor compliance. In fact,
breast-feeding resulted in the least cumulative mortality
only when it was recommended for six months and there
was 100% (very high) compliance. Poor compliance
could be expected to result in mixed-feeding with its con-
sequences: higher infection rates, more infants who are
HIV positive and who die later on. If the aim was solely to
reduce mortality, then recommending breast-feeding
(including breast-feeding for shorter durations) could
only be justified when mortality in replacement-fed
infants was greater than 50 per 1000 per year, the rate of
infection in exclusively breast-fed infants was less than 2
per 1000 breast-fed infants per week, the rate of progres-
sion from HIV to AIDS was less than 15 per 1000 infected
infants per week, or the mortality due to HIV/AIDS was
less than 200 per 1000 infants with HIV/AIDS per year.
Reducing the recommended duration of breast-feeding
resulted in fewer children living with HIV/AIDS. However,
recommending replacement-feeding (even with poor
compliance) resulted in the least number of children liv-
ing with HIV/AIDS. This suggests that if the aim was solely
to reduce the number of children living with HIV/AIDS
then replacement-feeding would be the optimal choice
irrespective of mortality and rates of HIV transmission
and progression.
Considering the minimization of the total number of chil-
dren with HIV/AIDS or dead as main objective, replace-
ment-feeding was the best option in nearly all scenarios,
the exception being when the mortality in replacement-
fed infants was greater than 150 per 1000 infants or when
the mortality rate in replacement-fed infants was more
than 3.5 fold that in breast-fed infants.Page 10 of 13
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durations of breast-feeding in this simulation supports
WHO's recent update of its guidelines to recommend
exclusive breast-feeding for six months unless replace-
ment-feeding is AFASS. It may however be difficult for
policy-makers, attempting to implement WHO guide-
lines, to determine the extent to which replacement-feed-
ing in their settings is AFASS. Our simulations suggest that
replacement-feeding may not be considered safe unless
the mortality rate in replacement-fed infants is less than
three times that in exclusively breast-fed infants.
The deterministic nature of this simulation may be a lim-
itation because of its inherent assumption that the param-
eters and outcomes were fixed (having no variance).
Furthermore, as for every mathematical simulation, the
conclusions from our analysis could be limited by the
veracity of the model selected as well as the limitations of
the studies from which parameters were extracted. Our
analysis is however strengthened by its particular useful-
ness to sub-Saharan countries as we used parameters spe-
cific to conditions in this high-HIV prevalence setting.
Although the parameters used in the baseline model may
differ between published studies and may be biased
because of defects in the original studies, the impact of
varying them was addressed in the sensitivity analysis.
This sensitivity analysis of model assumptions showed
our findings to be robust within the range of plausible
parameters. Furthermore our findings are consistent with
a recently published report by Becquet et al. who did not
find any significant difference in the 2-year cumulative
mortality of exclusively breast-fed infants and replace-
ment-fed infants in West Africa[24].
Conclusion
In conclusion, this analysis presents a framework to assist
decision-makers in resource-limited settings in the choice
of which infant-feeding method to recommend for infants
born to HIV-infected mothers. Recommending exclusive
breast-feeding in infants born to HIV-infected women in
these settings, instead of replacement-feeding, may poten-
tially result in very little gains in mortality. Furthermore,
although recommending shorter durations of breast-feed-
ing may substantially reduce infant HIV infection, it
might slightly increase mortality. When exclusive breast-
feeding for shorter durations is recommended, lower mor-
tality could be achieved by a simultaneous reduction in of
the rate of progression from HIV to AIDS and or HIV/
AIDS mortality, reductions that are obtainable by the use
of HAART in infants. Making HAART and better care avail-
able to infected-infants should thus be an imperative
whenever a community and/or policy-maker prefer exclu-
sive breast-feeding over replacement-feeding.
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Impact of mortality rate in replacement-fed infants on the Number of 
Children with HIV/AIDS (top graph), dead (middle graph) or both (bot-
tom graph) at 2 years. U: Exclusive replacement-feeding (ERF) with 
100% compliance; V: EBF for 6 months with 100% compliance; W: EBF 
for 4 months with 100% compliance: X: ERF with 70% compliance; Y: 
EBF for 6 months with 85% compliance; Z: EBF for 4 months with 85% 
compliance.
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Additional file 2
Impact of the rate of infection in breast-fed infants on the Number of Chil-
dren with HIV/AIDS (top), dead (middle) or both (bottom graph) at 2 
years. U: Exclusive replacement-feeding (ERF) with 100% compliance; 
V: EBF for 6 months with 100% compliance; W: EBF for 4 months with 
100% compliance: X: ERF with 70% compliance; Y: EBF for 6 months 
with 85% compliance; Z: EBF for 4 months with 85% compliance.
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